In Brief: Biopharmaceutics
This article was originally published in The Tan Sheet
Biopharmaceutics: Completes acquisition of Koromex, Vaginex and Feminique feminine product lines from London International Group subsidiary U.S. Holdings, Inc., the company announced March 18. Biopharmaceutics is planning line extensions for the brands, which currently generate annual sales of approximately $4 mil. ("The Tan Sheet" March 11, In Brief)...
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC